Assignee
HIGH POINT PHARMACEUTICALS LLC
US·34 granted patents·8 pending applications·258 citations·filing 2003–2014
Top patents by PatentIndex Score
42 records- 0197US7501405B2Combination therapy using an 11β-hydroxysteroid dehydrogenase type 1 inhibitor and an antihypertensive agent for the treatment of metabolic syndrome and related diseases and disordersHIGH POINT PHARMACEUTICALS LLC·Filed 2005·Granted Mar 10, 2009·55 cites·3 claims
- 0295US7943613B2Compounds, their preparation and useHIGH POINT PHARMACEUTICALS LLC·Filed 2006·Granted May 17, 2011·22 cites·24 claims
- 0393US8551993B2Phenoxy acetic acids as PPAR delta activatorsHIGH POINT PHARMACEUTICALS LLC·Filed 2012·Granted Oct 8, 2013·13 cites·12 claims
- 0493US8362016B2Phenyl propionic acids as PPAR delta activatorsHIGH POINT PHARMACEUTICALS LLC·Filed 2011·Granted Jan 29, 2013·15 cites·11 claims
- 0593US7723323B2Pharmaceutical use of fused 1,2,4-triazolesHIGH POINT PHARMACEUTICALS LLC·Filed 2008·Granted May 25, 2010·32 cites·14 claims
- 0690US7709528B2Compounds, their preparation and useHIGH POINT PHARMACEUTICALS LLC·Filed 2006·Granted May 4, 2010·15 cites·35 claims
- 0790US7700583B211β-hydroxysteroid dehydrogenase type 1 active compoundsHIGH POINT PHARMACEUTICALS LLC·Filed 2005·Granted Apr 20, 2010·30 cites·17 claims
- 0887US8344001B2Heterocyclic H3 antagonistsHIGH POINT PHARMACEUTICALS LLC·Filed 2008·Granted Jan 1, 2013·10 cites·36 claims
- 0986US8053431B2Pharmaceutical use of substituted amidesHIGH POINT PHARMACEUTICALS LLC·Filed 2006·Granted Nov 8, 2011·9 cites·8 claims
- 1085US8053447B211β-hydroxysteroid dehydrogenase type 1 active compoundsHIGH POINT PHARMACEUTICALS LLC·Filed 2007·Granted Nov 8, 2011·7 cites·10 claims
- 1185US8048908B211β-hydroxysteroid dehydrogenase type 1 active compoundsHIGH POINT PHARMACEUTICALS LLC·Filed 2007·Granted Nov 1, 2011·4 cites·6 claims
- 1284US7943669B2Phenoxy acetic acids as PPAR delta activatorsHIGH POINT PHARMACEUTICALS LLC·Filed 2006·Granted May 17, 2011·7 cites·25 claims
- 1383US7915299B22-(2-hydroxyphenyl)benzimidazoles useful for treating obesity and diabetesHIGH POINT PHARMACEUTICALS LLC·Filed 2007·Granted Mar 29, 2011·6 cites·8 claims
- 1483US7893267B2Benzazole derivatives, compositions, and methods of use as β-secretase inhibitorsHIGH POINT PHARMACEUTICALS LLC·Filed 2006·Granted Feb 22, 2011·6 cites·8 claims
- 1580US7943612B2Compounds that modulate PPAR activity, their preparation and useHIGH POINT PHARMACEUTICALS LLC·Filed 2007·Granted May 17, 2011·4 cites·14 claims
- 1679US7939690B2Haloalkylsulfone substituted compounds useful for treating obesity and diabetesHIGH POINT PHARMACEUTICALS LLC·Filed 2007·Granted May 10, 2011·4 cites·19 claims
- 1778US7816385B2Dimeric dicarboxylic acid derivatives, their preparation and useHIGH POINT PHARMACEUTICALS LLC·Filed 2003·Granted Oct 19, 2010·9 cites·10 claims
- 1876US9163022B2Tricyclic compounds as modulators of TNF-α synthesis and as PDE4 inhibitorsHIGH POINT PHARMACEUTICALS LLC·Filed 2014·Granted Oct 20, 2015·1 cites·19 claims
- 1975US8053598B2Compounds, their preparation and useHIGH POINT PHARMACEUTICALS LLC·Filed 2005·Granted Nov 8, 2011·2 cites·49 claims
- 2075US7964608B2Tricyclic compounds as modulators of TNF-α synthesisHIGH POINT PHARMACEUTICALS LLC·Filed 2009·Granted Jun 21, 2011·1 cites·48 claims
- 2175US7799924B2Substituted homopiperidine, piperidine or pyrrolidine derivativesHIGH POINT PHARMACEUTICALS LLC·Filed 2007·Granted Sep 21, 2010·2 cites·11 claims
- 2273US8383820B2N-adamantyl benzamides as inhibitors of 11-β-hydroxysteroid dehydrogenaseHIGH POINT PHARMACEUTICALS LLC·Filed 2008·Granted Feb 26, 2013·1 cites·46 claims
- 2373US7645791B2Salicylic anilidesHIGH POINT PHARMACEUTICALS LLC·Filed 2008·Granted Jan 12, 2010·1 cites·17 claims
- 2472US8946259B2Benzazole derivatives, compositions, and methods of use as beta-secretase inhibitorsHIGH POINT PHARMACEUTICALS LLC·Filed 2013·Granted Feb 3, 2015·1 cites·3 claims
- 2571US7968723B2Compounds, their preparation and useHIGH POINT PHARMACEUTICALS LLC·Filed 2005·Granted Jun 28, 2011·1 cites·52 claims
- 2671US2009264412A1Combination Therapy Using An 11beta-Hydroxysteroid Dehydrogenase Type 1 Inhibitor And A Glucocorticoid Receptor Agonist To Minimize The Side Effects Associated With Glucocorticoid Receptor Agonist TherapyHIGH POINT PHARMACEUTICALS LLC·Filed 2009·Application pending·0 cites
- 2766US2010120743A111Beta-Hydroxysteroid Dehydrogenase Type 1 Active CompoundsHIGH POINT PHARMACEUTICALS LLC·Filed 2009·Application pending·0 cites
- 2864US2009264435A1Novel Aryl- and HeteroarylpiperazinesHIGH POINT PHARMACEUTICALS LLC·Filed 2009·Application pending·0 cites
- 2962US2010075932A1Novel salicylic anilidesHIGH POINT PHARMACEUTICALS LLC·Filed 2009·Application pending·0 cites
- 3061US8907096B2N-adamantyl benzamides as inhibitors of 11-β-hydroxysteroid dehydrogenaseHIGH POINT PHARMACEUTICALS LLC·Filed 2014·Granted Dec 9, 2014·0 cites·24 claims
- 3157US8809540B2N-adamantyl benzamides as inhibitors of 11-beta-hydroxysteroid dehydrogenaseHIGH POINT PHARMACEUTICALS LLC·Filed 2013·Granted Aug 19, 2014·0 cites·24 claims
- 3257US8378097B23-(1,3-benzodioxol-5-yl)-6-(4-cyclopropylpiperazin-1-yl)-pyridazine, its salts and solvates and its use as histamine H3 receptor antagonistHIGH POINT PHARMACEUTICALS LLC·Filed 2007·Granted Feb 19, 2013·0 cites·11 claims
- 3353US8022066B22-(2-hydroxyphenyl) benzothiadiazines useful for treating obesity and diabetesHIGH POINT PHARMACEUTICALS LLC·Filed 2007·Granted Sep 20, 2011·0 cites·5 claims
- 3452US7767695B2Substituted piperidinesHIGH POINT PHARMACEUTICALS LLC·Filed 2004·Granted Aug 3, 2010·0 cites·4 claims
- 3551US8383683B2Pharmaceutical use of substituted amidesHIGH POINT PHARMACEUTICALS LLC·Filed 2008·Granted Feb 26, 2013·0 cites·6 claims
- 3651US2009264414A1Amide Derivatives and Pharmaceutical Use ThereofHIGH POINT PHARMACEUTICALS LLC·Filed 2009·Application pending·0 cites
- 3749US7582673B2Bissulfonamide compounds as agonists of GalR1, compositions, and methods of useHIGH POINT PHARMACEUTICALS LLC·Filed 2005·Granted Sep 1, 2009·0 cites·53 claims
- 3848US8383668B211-beta-hydroxysteroid dehydrogenase type 1 active compoundsHIGH POINT PHARMACEUTICALS LLC·Filed 2011·Granted Feb 26, 2013·0 cites·3 claims
- 3947US2010197658A1Pharmaceutical use of fused 1,2,4-triazolesHIGH POINT PHARMACEUTICALS LLC·Filed 2010·Application pending·0 cites
- 4044US2010210653A1Novel Compounds, Their Preparations and UseHIGH POINT PHARMACEUTICALS LLC·Filed 2010·Application pending·0 cites
- 4139US8350039B2Substituted isoquinoline derivatives, pharmaceutical compositions, and methods of use as beta-secretase inhibitorsHIGH POINT PHARMACEUTICALS LLC·Filed 2011·Granted Jan 8, 2013·0 cites·17 claims
- 4238US2011009420A1Histamine H3 Receptor LigandsHIGH POINT PHARMACEUTICALS LLC·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when HIGH POINT PHARMACEUTICALS LLC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →